Geovax Labs Inc (GOVX)
2.06
-0.04
(-1.90%)
USD |
NASDAQ |
Oct 04, 16:00
2.06
0.00 (0.00%)
After-Hours: 20:00
Geovax Labs Research and Development Expense (Annual): 20.72M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.72M |
| December 31, 2022 | 9.124M |
| December 31, 2021 | 15.55M |
| December 31, 2020 | 2.444M |
| December 31, 2019 | 1.911M |
| December 31, 2018 | 1.879M |
| December 31, 2017 | 2.017M |
| December 31, 2016 | 1.971M |
| December 31, 2015 | 1.693M |
| December 31, 2014 | 1.813M |
| December 31, 2013 | 2.915M |
| December 31, 2012 | 3.044M |
| December 31, 2011 | 4.276M |
| December 31, 2010 | 4.794M |
| Date | Value |
|---|---|
| December 31, 2009 | 4.069M |
| December 31, 2008 | 3.742M |
| December 31, 2007 | 1.757M |
| December 31, 2006 | 0.6659M |
| December 31, 2005 | 1.641M |
| December 31, 2004 | 2.567M |
| December 31, 2003 | |
| December 31, 2002 | |
| December 31, 2001 | |
| December 31, 2000 | |
| December 31, 1999 | 0.5103M |
| December 31, 1998 | 1.576M |
| December 31, 1997 | 0.8278M |
| December 31, 1996 | 0.0767M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
1.911M
Minimum
2019
20.72M
Maximum
2023
9.951M
Average
9.124M
Median
2022
Research and Development Expense (Annual) Benchmarks
| Emergent BioSolutions Inc | 111.40M |
| Tonix Pharmaceuticals Holding Corp | 86.66M |
| Co-Diagnostics Inc | 22.96M |
| SIGA Technologies Inc | -- |
| Applied DNA Sciences Inc | 3.735M |